and thank you results more joining announce in we fiscal quarter Amy, our fourth shareholders our full our as XXXX from us year detail. for results and to review Thanks,
patients way screening, very lowest and with various outcomes, seems in for apnea quarter, cost therapy, the ResMed the with strong execution double-digit incredibly sleep efficacious in global of producing market-leading even and their especially business all line is therapies against generators segments airway growth interest our to therapy our performance a helping well flow be in most and Our positive regions the of bottom pressure year-over-year another new across tough across our which and executed period solid fourth strong remained business the demand patient Media team therapy. and comparable. our quarter, best robust and diagnosis to growth.
Ongoing all all find
start are and our terms when choosing in business, strong of in they continue through patients resupply, business. and resulting respiratory physicians they ResMed masks therapy accessories In accessories and and masks very therapists growth our as double-digit masks
software residential and business revenue in net care profit. growth Our operating delivered double-digit in
has as Our of into continue trajectory pulmonary launch neuromuscular suffer growth, delivered XXXX.
Over fiscal another operating worldwide to to and laser insomnia billion due on year focus obstructive well sleep we're profitable or we chronic this positioned from respiratory or people on strong leverage disease disease. apnea, insufficiency quarter X.X
ResMed These a As penetration the is increased we're and epidemic respiratory in market leader positioned health drive conditions breathing chronic health and form ResMed, growth. generation sleep care medicine positioned through globally, market at that to residential in address.
We demand home. be accelerate well possible. X believe ResMed here to billion location people health uniquely global in own health lowest right In acuity the in clear is a highest of leader in that's a globally. that the delivered should sleep apnea, person's and the care comfort case, cost, optimal market lowest to over
connectable XX improve new medical outcomes latest the solutions worldwide.
We've remain medical end data remain these the curve therapy We're patients industry consumer lower cloud cutting cloud the into in million to the and countries XX data Our XXX show the of from technology and at in more of significantly disease system. latest leading and industry in care nights Significant edge the big from companies medicines that will our progression. chronic opportunities leveraged advances bring devices health be plan there into health and the The digital markets of approximately solutions costs, with right and digital we more wearables pharmaceutical health, in XXX% to billion sold over bend underpenetrated. de-identified innovation.
we're breathing focused of from and sleep, device to get We improving costs on patient every globally. better who home.
Sales the people benefit our Billions global connectable our XX. solutions, outcomes. flow devices, supporting pathway people and expanding and XX better has AirSense market our can lowering expanding interoperability better on XX care grew We're of a and reach platform patient platforms, their at AirSense generator have help to the opportunities many access market needs products XXX% add growing and value, category-leading the to our and including to the market-leading X% cloud year-over-year the and AirSense
worldwide and regulatory technologies country increasing and secure production launch XX clearances the these country. AirCurve our of platforms availability by our continue We AirSense as and XX market-leading we
Our category globally. accessories year-over-year, competitive masks and business grew expanding in a XX%
well introduced last AirFit FXX Our extremely markets innovation, latest that launched in. doing the quarter is mask in the has it
New our directly. ongoing with smallest programs of can long-term and programs profile selecting we're programs the voting use. that in their voting the by our ResMed. the for ecosystem, patients and shows improve on are subscription we FXX health is Masks the and very its providers. Brightree Patients AirView the patients including resupply fit successfully or of and resupply our directly important for protocols patients. physicians establishing for therapy respiratory comfort, are It our with are and from ease setup are programs with mask consumers wallets voting digital market outcomes.
In for as programs therapists their nasal global markets and FXX medical clinical both to partner providers as patient their adherence the countries introduce serve with to to are clinical myAir and availability to globally. patients home countries U.S. Research cash increase powered U.S., physicians the and drive commercial offering physicians, their look to in improve part prescriptions. needs path equipment resupply year into continue therapy and a We accessory we find help across teams of pay their resupply ongoing forward with more resupply throughout and fiscal and XXXX.
ResMed's success more and are
regularly their their therapy continue launch and programs scale refreshing health, needs. develop, control ongoing people to own to will take We and technologies these help of
opportunity grow pursue health the and breathing each to be as care. expand better is most awareness, leader person market personal in As and better better residential diagnosis journey the their to markets, for through We treatment. to seamless global they concierge pathways significantly to underpenetrated sleep, and the our important aspire digital
find investing concerned personal their in well up to are are find demand media-driven diagnosis, to as ramping to help for generation traditional way -- and campaigns them management own into ways help treatment their sleep We're who appropriate awareness care health as access patients create cost-effective their to demand generation and initiatives breathing social for and raise serving about care breathing our pathways. sleep pathways channels We health. health their screening, consumers and
patients ecosystem in records. patient contains over XX now consumer which remains physicians now of and the over as as showing well health personalized million million own engagement measure health journey quarter, patient people accessing active our incredibly myAir, personal provider app data users. and X.X These software journey. called includes called choose every based their physician to sleep participate their is progress of AirView health their where to growing Adoption digital are in Our engagement ecosystems along
such As of sleep will Watch for Galaxy driven companies, Samsung support discussed consumer we capabilities FDA Watch, issues the further moderate future, and expect in Whoop tracking to global a from Awareness consumer sleep sleep wearable Fitbit, tech, the screen specifically believe that megatrends and I de X Aura Google's players as technology by And clearance look which health ResMed. novo ongoing like other severe [indiscernible]. for growth I've to has Apple wearables to similar the the Ring, apnea. we
as at entering of future pharmaceutical of are In behind patients companies volumes we X terms pharma on in diabetes increase seeing significant tech megatrends obesity the continue the increased into research treatments by these and medicines will of big and Together, apnea. driven awareness we of believe these patient growth, they tailwind awareness be the the for efforts ResMed. increase they patient their second big growth medicines care the system for megatrend long-term and health consumer and a of impacts here sleep
sleep tracking seeking we to advice to call of sleep what health to is pathway a care we true move professional into opportunity. help, in medicine. sleep of the awareness pathway what This digital issues field tracking are and calling concierge call the from where care and health wearable a we goal from of Our as people on health are consumer they health health educate health wellness is they sleep connection would a breathing what
focused there that as management on of life.
Big is to for for through of they screening, and person Pharma be health plan process and squarely is treatment medications. GLP-X go their health breathing the their Our ongoing diagnosis, sleep
that increased they physicians their for. diseases in they been focused care funnel, activating and previously of open people ultimately obesity other Triumvirate new dealing people into health sleep while to goals of care exercise many them as will to treating into obesity may improving and maintain they weight GLP-Xs chronic strive new the may cardiovascular not diet, up apnea that are build bring on will sleep but treatment losing driving care or loss.
We We issues, [ their from, believe with patients of Health. to suffer them routines, believe diagnosis something health this called increased For that awareness to considered ] see diabetes treated their the their including have and primary achieve weight, and treat them utilization their many pathways,
what ResMed apnea focus therapy. a latest study loss in that but patient driving patients.
The we patients our This on the claims emphasis GLP-X will So through demonstrates real-world having XXX,XXX driving thesis. spotlight our the have an analysis in also subjects an net are from it's positive third-party positive the be and cohort our just business of airway has GLP-Xs to over previously. the in presented increased sleep data, seeking which using data a de-identified has motivated of are drugs on our into impact big like biggest impact analysis. a believe weight by to pharma not expanded of before. the channel, field medications We evidence pressure analysis added GLP-Xs and de-identified never adhering for we now The a numbers growth that more put on support have patients believe leveraging improvement is more it's and that data.
We and both positive
with For motivated higher this GLP-X to show therapy. those that start propensity XX.X points CPAP, latest data APAP data absolute patients These their patients prescribed prescription. are therapy PAP a without to GLP-X bilevel drug a percentage or more the start prescription a show over medication,
months on we at that seen terms XX have points. T equals rate the of In resupply impacts longer-term therapy, is XXX basis PAP
promise this our brand ensure path or more bringing further absolute So PAP detail.
ResMed patients the it's and patients system. a encourage ResMed GLP-X the most efficacy, further, in prescription. XXX X.X system. lowest patients obligation review basis at earnings analysis for and the health percentage highly find resupply is quarterly class believe Frankly, to new PowerPoint resupply We've breathing who their is These is sleep is T we consumers the health health leader percentage health and for the sleep data rate care for that's included who is show them. absolute for in home. months, our our clear care you into that, therapy it's the highest in the And points business, the than care the comfortable out health, it therapy deck, to that and prescription. concern at there pharmaceutical world It's cost equals have have points into for brand a GLP-X promise. and X.X% there delivered I that data best points updated higher XX more tailwind patients a And bringing to motivated higher our clear
XX% market-leading reviewed platforms digital to and PAP to over adherence health XX% myAir the published AirView. and that days we device PAP demonstrates evidence with first Our combining can our XX technology peer in solutions, by technology, achieve
scenario XX% And of that still to need help alternatives. Of course, ResMed wants too. to means that be that in there those patients patients
printed their that in So dental to And device treatment help with includes Western apnea ResMed alternative investing dental devices for PAP market-leading we can't the sleep treatment second-line therapies. who Northern to of provides dental Narval, Europe. in therapy patients pathway are find XD where therapies to and adhere to
nerve In addition, including stimulation our hypoglossal third-line investment in and therapies, Nyxoah. options we in with in technology our pharmaceutical have with investments investment Apnimed
ecosystem back an deidentified broadly step data. investments, medical technology extraordinary billion let's of XX health talk almost So leveraging and our digital nights of about
AI We products expand a intelligence-driven as launching to into our of ecosystem. customer-facing well artificial portfolio are continuing we're developing market from as and capabilities that the
a coaching in few new We is new expanding smart expand AI our fiscal the to out pilot QX continue XXXX compliance roll our and year coach we as and of the United and go States AirView, beyond. is products quarter, countries which into through in such which current as
help a business Care home strong Brightree of our our Software what can into awareness. a home business, our our another do to share and business. to the our very not driving throughout enhance importantly, Pac tech, and it And software experience the is operating simple on user their generic to double-digit sector front fiscal in as MEDIFOX residential in DAN sun quarter provider.
In our made XXXX. U.S. double-digit going from segment strong single-digit rising region, consumer generative well growth high and AI we in health nursing Gen we're is focused further with our fiscal that capabilities. progressing recently outcomes, the leverage, a Dawn. growth growth very business brand very project a this XXXX. this AI We'll drive Service We've the progress is for strength as care that business Dawn Residential with each business journey. but patients of well It's really to as we're our by expanded great also as in year in A to Asia concierge on provider the within physician, initially But that AI market. had net and are continue AI going home with Asia our XX%, developed And growth brand. good year-over-year supported maintain tech patient, have quarter generative Pacific through and at medical to profit growth ML XXXX, of scaled our yes, We we as equipment sleep from a low across after to Dawn we sleep. strong nursing operating piloted call night was plan a was along reference what our we're progress and and throughout
businesses. care residential growth ResMed broader integral synergistic software ongoing the business Our our portfolio across to is with growth opportunities
residential resupply we're mask business accelerating the core We helping and growth but are care growth. across our to through business software support also intrinsically, accessory
health businesses compute, sleep managing software our our with development We cloud health leverage and continue operating drive research managed by privacy, interoperability, across to platforms our and velocity across core capabilities cybersecurity, such and with as breathing businesses. and
residential transforming scale. medicine care respiratory at are We and software
adopting that industry we the leading are We and technology health across in countries the developing, XXX-plus serve. applying digital
continue industry driving drive profitability customers focused performance.
We We shareholders. operating digital that technologies. with in scale the growth this non-GAAP global most XX%. on of quietest, incredibly excellent income global our also connected line. to strong delivered than quarter. solutions growth but in made smallest, the growth global and progress team to bottom efficiencies I'm efficiencies long-term net more products at increasing our and most comfortable, in The in with discipline technology lead non-GAAP for We're and operations. on for team top line and The proud of delivered accelerate the team their and income XX%. revenue We of intelligent our value most We worldwide, differentiated provide sustainable driving health cost
XXX in over and our XX,XXX-plus better, to provides day my hand XX digital last the the for and solution personal up work care that or Resmedians have in months, today to where directly and health mask by CFO, live his a Over who's and delivering right they global across with remarks, I that, helped million health patient morning Sydney. over lives their sleep we'll dedication you, this Sydney to call you, patient want closing, we live.
In We've a lives I'll perseverance, here XXX breathe to Thank a to and with person improved or then directly countries. delivered a software express high-quality the medical Q&A team.
With each Brett, every a to for gratitude sincere During San complete device Diego best-in-class care. to hard open Brett. team better
